Violett develops Luminair that disinfects pathogens in the air to breathe.
Violett has raised $2.3M in total funding. The most recent round was Seed. The last funding was announced in August 2022.
Violett's investors include Pack Ventures, TVF, Alliance of Angels, Luana Investments.
Violett is headquartered in Gig Harbor, United States.
Violett develops Luminair that disinfects pathogens in the air to breathe.
Violett is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Violett — Funding & Investors." VCBacked, August 1, 2022, https://www.vcbacked.co/company/violett. Accessed September 30, 2026.
VCBacked. (2022). Violett — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/violett
{{cite web |title=Violett — Funding & Investors |url=https://www.vcbacked.co/company/violett |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated